Parizvino, COVID-19 ichiri mumamiriro edenda kutenderera pasirese. Iyo yepamusoro yeDelta neOmicron misiyano yakawanda, zvichikonzera kuenderera mberi kwekusimudzira kugona kwavo kutapurirana. Pakati pemafungu akadzokororwa eCCIDID-19, kuwedzera kune COVID-19 yekudzivirira, kuvandudzwa kwemishonga yemuromo yeCCIDID-19 uye nzira dzinokurumidza, dzakareruka uye dzehunyanzvi dzekuyedza zvakare dzave kudiwa kutsva kwekudzivirira uye kutonga kwedenda. Viva Biotech Holdings uye XLement, yakadyarwa uye yakanyudzwa neViva BioInnovator, yakazvipira kugadzirwa kwemishonga yemuromo COVID-19 uye bvunzo dzehutachiona, zvichibatsira mukurwisa denda reCCIDID-19.
Langhua Pharmaceutical zviratidzo chibvumirano neMPP kugadzira mbishi yeCOVID-19 antiviral mushonga molnupiravir.
Ndira 2022, iyo Medicines Patent Pool (MPP) yakazivisa kuti yakasaina zvibvumirano nemakambani akati wandei ekugadzira mageneric anosanganisira Zhejiang Langhua Pharmaceutical Co., Ltd (Langhua Pharmaceutical), iyo inotsigira Viva biotech holdings (Viva Biotech (01873.HK)) kugadzirwa kwemushonga weCCIDID-19 antiviral molnupiravir uye kupihwa munyika zana neshanu dzine mari yepakati nepakati (LMICs) kufambisa mukana wepasi rose wemolnupiravir uye kutsigira kudzivirira nekudzora denda. Makambani mashanu anozotarisana nekugadzira zvimisikidzo, makambani gumi nematatu achagadzira zvese zvakabikwa uye mushonga wapera uye makambani mapfumbamwe achagadzira mushonga wapera.
The Medicines Patent Pool (MPP) isangano reUnited Nations-rinotsigirwa neveruzhinji riri kushanda kuwedzera kuwaniswa, uye kufambisa kugadzirwa kwemishonga inoponesa upenyu kunyika dzine mari yakaderera nepakati. MPP neMSD, zita rekutengeserana reMerck & Co., Inc Kenilworth NJ USA yakasaina chibvumirano chekuzvidira rezenisi muna Gumiguru 2021. Pasi pemitemo yechibvumirano, MPP, kuburikidza nerezinesi rakapihwa neMSD, ichabvumidzwa kuenderera mberi nerezinesi risiri rega. marezinesi kune vanogadzira ("MPP Rezinesi") uye kusiyanisa nzvimbo yekugadzira yekugovera yemhando-yakavimbiswa molnupiravir kunyika dzakafukidzwa neMPP Rezenisi, zvichienderana nemvumo yepamutemo yemuno.
Molnupiravir (MK-4482 uye EIDD-2801) inzira yekuferefeta, inopihwa nemuromo fomu ine simba ribonucleoside analog iyo inodzivisa kudzokororwa kweSARS-CoV-2 (iyo causative agent yeCOVID-19). Molnupiravir iyo MSD iri kusimukira yakabatana neRidgeback Biotherapeutics, ndiyo yekutanga mushonga wepamuromo antiviral unowanikwa paCOVID-19 kurapwa. Dhata kubva kuChikamu 3 MOVe-OUT yakaratidza kuti kurapwa kwekutanga ne molnupiravir kwakaderedza zvakanyanya njodzi yekuiswa muchipatara kana kufa munjodzi huru, vanhu vakuru vasina vaccine neCOVID-19.
Sekureva kweMPP, makambani akapihwa rezinesi iri akabudirira kuratidza kugona kwavo kuzadzikisa zvinodiwa neMPP zvine chekuita nekugadzirwa, kutevedza mitemo, uye kugona kuzadzisa mwero wepasi rose wemishonga inovimbwa. Mvumo yakapihwa kuLanghua Pharmaceutical neMPP inomiririra kusimbiswa kwepamusoro uye kucherechedzwa mukuvandudza kwayo maitiro uye kukwidziridzwa kweAPIs, kuenderera kwekupa, GMP uye EHS system.
Xlement's COVID-19 Test Kit Yakapasa Kuongororwa kweBazi reSainzi neTekinoroji yePeople's Republic of China Zvakabudirira.
Musi waKurume 2, 2022, Xlement, yakazvipira NanoSPR biochip uye zviridzwa zvebiotech kambani yakadyara mari uye yakasimudzwa neViva BioInnovator, yakagamuchira chiziviso chekupasa ongororo yekushanda kubva kubazi reSainzi neTekinoroji rePeople's Republic of China. Chirongwa chayo "R&D uye Mass Production yeNanoSPR COVID-19 Particle Test Kit" ndechimwe chezvirongwa zvakakosha zve "Public Safety Risk Prevention and Control uye Emergency Response Technology uye Equipment" chirongwa chinopa chikamu chakakosha kukiyi COVID-19- tsvagiridzo yesainzi yakabatana iri kuitika muChina. Nekupasa kwayo kwakabudirira pakuongorora, Xlement's COVID-19 Test Kit zvakare yakasimbiswa neEuropean Union CE yekugadzirwa kukuru kweramangwana uye ichashandiswa munguva pfupi iri kutevera.
Yakasimudzwa pane yakasarudzika NanoSPR chip tekinoroji, Xlement yakagadzira bvunzo kit yeCCIDID-19 zvimedu, izvo zvinobvumira nhanho-imwe bvunzo yeakawanda hutachiona maantigens makumi mapfumbamwe nematanhatu masampuli mukati memaminitsi gumi nemashanu, uye kunzwa kuri pedyo nekuyedza antigen imwechete. Iyi nzira inoratidza mabhenefiti makuru kana ichienzaniswa nearipo hutachiona nucleic acid yekuongororwa maitiro: inogona kushandiswa kuzviongorora pamba, inopfupisa nguva yekuyedza zvakanyanya, nokudaro, inoderedza zvakanyanya mutengo wekuyedza reagents uye kushanda. Nekuwedzera kutorwa kweiyo NanoSPR tekinoroji muCCIDID-96 bvunzo yakagadziriswa neXlement, isu tinotarisira kuona zviri nyore nekukasira kuongororwa kweanofungidzirwa masampuli uye pa-saiti nekukurumidza kuongororwa pakukura.
